MediPoint: Enteral Stents - APAC Forecast and Market Analysis
Enteral stents market is a growing medical market throughout all geographies. The market is driven primarily by rising cancer rates, specifically esophageal, stomach, pancreatic, and colorectal cancers, and by an increased awareness of stenting as a palliative treatment. Overall, the fully covered enteral stents account for the largest market share, followed by partially covered enteral stents, and both of these markets are growing throughout the forecast period. The non-covered enteral stents market, however, is a declining market, as they are more likely to result in tumor ingrowth and result in further complications. This trend is seen throughout the global enteral stents market.
Enteral stents are a palliative treatment option for constrictions caused primarily by various cancers. The primary cancers which cause constrictions requiring the use of enteral stents are esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer. There are three primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the non-covered enteral stent.
The APAC market for enteral stents, which encompasses seven countries and includes esophageal stents, gastrointestinal stents, and colonic stents, was valued at approximately $67.3M in 2016. The market is expected to grow at a CAGR of 3.5%, to reach a valuation of $85.5M in 2023.
The key drivers of this market during the forecast period are -
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook